Back

American Society for Metabolic and Bariatric Surgery

  • Gastrectomy
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Kidney Failure, Chronic
  • Kidney Transplantation
  • Obesity

August 2025 B: Sleeve gastrectomy versus GLP-1 agonist to improve kidney transplant access in end-stage renal disease patients with obesity: a decision analysis

1. Discuss the use of GLP-1 agonists for weight management in patients with ESRD. Identify the optimal weight loss intervention for improving access to kidney transplantation in patients with ESRD and obesity. Identify and discuss the impact of different weight loss interventions on long-term survival in patients with ESRD and obesity. Demonstrate how Markov decision models provide a framework to evaluate multiple weight loss interventions in a complex population

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

This is a journal-based activity. Credit is earned after completing the required reading and assessment; the amount shown is the provider-reported available credit.

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

ABS — Accredited CMEUp to 1 pointABS — Self-AssessmentUp to 1 point

FDA REMS

No

Qualifies for MIPS

No
  • Journal-based
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Fee · varies
  • Released
    Aug 1, 2025
  • Last day to claim credit
    Aug 2, 2028 2 years left